Cancer
Malignant Gastric Neoplasm
CI-CAN-00001130Explore in graph →
Top-level652 active trials4 approved drugs55 evidence items
Loading cancer entity…
Cancer
CI-CAN-00001130Explore in graph →
Clinical trials
2,842 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (232)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04250402 | The Incidence of Gallstones After Gastric Cancer Surgery | completed | — | 1,019 | Hepatopancreatobiliary Surgery Institute of Gansu ProvinceOTHER | 1 | Nov 19, 2024 | clinicaltrials |
| NCT05965466 | The Incidence of Gallstones After Gastrectomy | completed | N/A | 531 | Hepatopancreatobiliary Surgery Institute of Gansu ProvinceOTHER | 1 | Nov 19, 2024 |
| NCT06690268 | Multimodal Model Predicts Recurrence(FUTURE12) | completed | — | 93 | Qun ZhaoOTHER | 1 | Nov 15, 2024 | clinicaltrials |
| NCT04292496 | Anastomotic Leak Testing in Gastrectomy | completed | N/A | 148 | Nanchong Central HospitalOTHER_GOV | 1 | Nov 14, 2024 | clinicaltrials |
| NCT06689462 | Appraisal of the Modified Cancer Cachexia Index in Locally Advanced Gastric Cancer Patients Undergoing Neoadjuvant Chemotherapy | completed | — | 600 | Fujian Medical UniversityOTHER | 1 | Nov 14, 2024 | clinicaltrials |
| NCT02578368 | Chemotherapy Alone vs. Chemotherapy + Surgical Resection in Patients With Limited-metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction(FLOT5) | completed | Phase 3 | 183 | Krankenhaus NordwestOTHER | 1 | Nov 12, 2024 | clinicaltrials |
| NCT06673472 | Comparison of Long-term Outcomes Between Upfront Surgery and Neoadjuvant Therapy Followed by Surgery in Patients with Node-Negative Gastric Cancer | completed | — | 1,081 | Chang-Ming Huang, Prof.OTHER | 1 | Nov 5, 2024 | clinicaltrials |
| NCT04871204 | Octreotide Treatment to Improve Nutritional Recovery After Surgery for Patients with Esophageal or Gastric Cancer(OTIS) | completed | Phase 2 | 20 | Fredrik KlevebroOTHER | 1 | Oct 31, 2024 | clinicaltrials |
| NCT06666582 | Real-world Data of Paclitaxel and Ramucirumab Compared to Other Treatment Regimens in Advanced Gastric Cancer | completed | — | 185 | Hellenic Cooperative Oncology GroupOTHER | 1 | Oct 30, 2024 | clinicaltrials |
| NCT02040142 | HIPEC for Peritoneal Carcinomatosis | completed | Phase 2 | 51 | Albert Einstein College of MedicineOTHER | 1 | Oct 24, 2024 | clinicaltrials |
| NCT05427214 | Imaging Study on Halcyon 4.0 System for Patients Receiving Radiation Therapy(Dragon) | completed | N/A | 52 | Washington University School of MedicineOTHER | 1 | Oct 21, 2024 | clinicaltrials |
| NCT06645912 | Effect of High Protein ONS on Older Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy | completed | N/A | 46 | Erzincan Binali Yildirim University Mengucek Gazi Training and Research HospitalOTHER_GOV | 1 | Oct 18, 2024 | clinicaltrials |
| NCT00582257 | Early Onset and Familial Gastric Cancer Registry | completed | — | 971 | Memorial Sloan Kettering Cancer CenterOTHER | 2 | Oct 3, 2024 | clinicaltrials |
| NCT04713891 | A Study of KF-0210 in Advanced Solid Tumors Patients | completed | Phase 1 | 14 | Keythera Pharmaceuticals (Australia) Pty LtdINDUSTRY | 1 | Sep 24, 2024 | clinicaltrials |
| NCT04253106 | Liquid Biopsies for the Personalized Management of Patients with Hereditary Diffuse Gastric Cancer(LISA-HDGC) | completed | N/A | 16 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Sep 23, 2024 | clinicaltrials |
| NCT00400179 | A Safety and Efficacy Study in Patients With Gastric Cancer | completed | Phase 3 | 1,053 | Taiho Oncology, Inc.INDUSTRY | 2 | Sep 19, 2024 | clinicaltrials |
| NCT02891447 | Heated Mitomycin and Cisplatin During Surgery in Treating Patients With Stomach or Gastroesophageal Cancer | completed | Phase 2 | 24 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT03453164 | Checkpoint Inhibitor and Radiotherapy for Recurrent Gastric Cancer (CIRCUIT) | completed | Phase 1 / Phase 2 | 41 | Fukushima Medical UniversityOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT04065139 | Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Gastric Carcinomatosis. Phase II Randomized Study(PIPAC EstoK 01) | completed | Phase 2 | 66 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT00072787 | Phase 1/2 Study of S-1 and Cisplatin in Advanced Gastric Cancer | completed | Phase 1 / Phase 2 | 41 | Taiho Oncology, Inc.INDUSTRY | 1 | Sep 3, 2024 | clinicaltrials |
| NCT02500043 | Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer | completed | Phase 3 | 507 | Taiho Oncology, Inc.INDUSTRY | 18 | Sep 3, 2024 | clinicaltrials |
| NCT06573307 | Hematological Dynamic Scores for Predicting Survival and Treatment Response for Advanced Gastric Cancer After Neoadjuvant Therapy | completed | — | 442 | Chang-Ming Huang, Prof.OTHER | 1 | Aug 27, 2024 | clinicaltrials |
| NCT06561516 | Effects of Red Ginseng on Gastrointestinal Symptoms and Microbiota After Surgery for Gastrointestinal Cancer | completed | N/A | 60 | Gangnam Severance HospitalOTHER | 1 | Aug 20, 2024 | clinicaltrials |
| NCT03647969 | Modified FOLFOX Plus/Minus Nivolumab and Ipilimumab vs. FLOT Plus Nivolumab in Patients With Previously Untreated Advanced or Metastatic Gastric Cancer | completed | Phase 2 | 262 | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus NordwestOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT03133286 | Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)(RADIANT) | completed | — | 16 | DxTerity DiagnosticsINDUSTRY | 1 | Aug 7, 2024 | clinicaltrials |
| NCT03852251 | A Study of AK104, a PD-1/CTLA-4 Bispecific Antibody, for Advanced Solid Tumors or With mXELOX/XELOX as First-line Therapy for Advanced Gastric or GEJ Adenocarcinoma | completed | Phase 1 / Phase 2 | 338 | AkesoINDUSTRY | 1 | Aug 2, 2024 | clinicaltrials |
| NCT02443324 | A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract Cancer | completed | Phase 1 | 175 | Eli Lilly and CompanyINDUSTRY | 6 | Jul 31, 2024 | clinicaltrials |
| NCT01839773 | Phase 3 Study to Compare Efficacy and Safety of DHP107 vs. Taxol® in Patients With Metastatic or Recurrent Gastric Cancer(DREAM) | completed | Phase 3 | 238 | Daehwa Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 25, 2024 | clinicaltrials |
| NCT04600518 | Single Patient Classifier (SPC) Prediction for Stage II and III Advanced Gastric Cancer(SPRINT) | completed | — | 2,047 | Novomics. Co., Ltd.INDUSTRY | 1 | Jul 22, 2024 | clinicaltrials |
| NCT06510088 | Effects of Multimodal Prehabilitation on Frail Elderly Patients Undergoing Elective Gastric Cancer Surgery | completed | N/A | 112 | Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical UniversityOTHER | 1 | Jul 19, 2024 | clinicaltrials |
| NCT06506331 | Impact of Preoperative VFA on Intraoperative Adverse Events in Patients Undergoing Laparoscopic Radical Gastrectomy | completed | — | 490 | Fujian Medical UniversityOTHER | 0 | Jul 17, 2024 | clinicaltrials |
| NCT06342427 | Stomach Cancer Exosome-based Detection(DESTINEX) | completed | — | 809 | City of Hope Medical CenterOTHER | 2 | Jul 8, 2024 | clinicaltrials |
| NCT05410535 | To Evaluate Efficacy of Ursodeoxycholic Acid (UDCA) for the Prevention of Gallstone Formation After Gasterectomy | completed | Phase 4 | 431 | Daewoong Pharmaceutical Co. LTD.INDUSTRY | 1 | Jun 28, 2024 | clinicaltrials |
| NCT06477562 | Surveillance Endoscopy After Proximal Gastriectomy With Double Tract Reconstruction. | completed | — | 160 | Saint Vincent's Hospital, KoreaOTHER | 1 | Jun 27, 2024 | clinicaltrials |
| NCT05688761 | Nordic Gastric and Esophageal Tumor Study(NordGETS) | completed | — | 900,000 | Karolinska InstitutetOTHER | 1 | Jun 24, 2024 | clinicaltrials |
| NCT04808791 | iTTo for Treatment Naive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma | completed | Phase 2 | 7 | AHS Cancer Control AlbertaOTHER | 1 | Jun 14, 2024 | clinicaltrials |
| NCT03382600 | Safety and Efficacy of Pembrolizumab (MK-3475) in Combination With TS-1+Cisplatin or TS-1+Oxaliplatin as First Line Chemotherapy in Gastric Cancer (MK-3475-659/KEYNOTE-659) | completed | Phase 2 | 100 | Merck Sharp & Dohme LLCINDUSTRY | 1 | Jun 11, 2024 | clinicaltrials |
| NCT03471494 | GlobalSurg 3: Quality and Outcomes in Global Cancer Surgery(GS3) | completed | — | 15,958 | University of EdinburghOTHER | 1 | Jun 7, 2024 | clinicaltrials |
| NCT05518929 | Hypoxia During Gastroenterological Endoscope Procedures Sedated With Ciprofol In Overweight Or Obesity Patients(SpO2) | completed | Phase 4 | 1,090 | RenJi HospitalOTHER | 1 | Jun 7, 2024 | clinicaltrials |
| NCT02318329 | Open-Label, Dose-Finding Study Evaluating Safety and PK of FPA144 in Patients With Advanced Solid Tumors | completed | Phase 1 | 79 | Five Prime Therapeutics, Inc.INDUSTRY | 3 | Jun 4, 2024 | clinicaltrials |
| NCT04400383 | Clinical Trial to Evaluate AB011 Injection in Patients With CLDN18.2-positive Advanced Solid Tumors | completed | Phase 1 | 62 | CARsgen Therapeutics Co., Ltd.INDUSTRY | 1 | May 24, 2024 | clinicaltrials |
| NCT06250075 | Effects of the Use of Probiotics on the Intestinal Microbiota of Patients With Gastric Cancer(PRONIC-G) | completed | N/A | 88 | Universidade Federal do AmazonasOTHER | 1 | May 13, 2024 | clinicaltrials |
| NCT03957031 | Gastric Cancer Risk Factors Associated With EU and CELAC Populations(LEGACY-1) | completed | — | 1,600 | Fundación para la Investigación del Hospital Clínico de ValenciaOTHER | 7 | May 9, 2024 | clinicaltrials |
| NCT04015466 | Advanced GC Multi-omic Characterization in EU and CELAC Populations(LEGACY-2) | completed | — | 800 | Fundación para la Investigación del Hospital Clínico de ValenciaOTHER | 7 | May 9, 2024 | clinicaltrials |
| NCT04019808 | Gastric Cancer Risk Factors Knowledge in European and Latinamerican Population(LEGACY-3) | completed | — | 800 | Fundación para la Investigación del Hospital Clínico de ValenciaOTHER | 7 | May 9, 2024 | clinicaltrials |
| NCT02267343 | Study of ONO-4538 in Unresectable Advanced or Recurrent Gastric Cancer | completed | Phase 3 | 493 | Ono Pharmaceutical Co., Ltd.INDUSTRY | 3 | May 3, 2024 | clinicaltrials |
| NCT02746796 | Study of ONO-4538 in Gastric Cancer | completed | Phase 2 / Phase 3 | 680 | Ono Pharmaceutical Co., Ltd.INDUSTRY | 3 | May 3, 2024 | clinicaltrials |
| NCT03006705 | Study of Adjuvant ONO-4538 With Resected Gastric Cancer | completed | Phase 3 | 800 | Ono Pharmaceutical Co., Ltd.INDUSTRY | 4 | May 3, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Nov 19, 2024source: clinicaltrials